Browse

GENOMIC AND HUMAN PAPILLOMAVIRUS PROFILING OF AN ORAL CANCER COHORT IDENTIFIES TP53 AS A PREDICTOR OF OVERALL SURVIVAL

Mucosal - HPV Negative

Neil Mundi, MD¹, Stephenie Prokopec², Farhad Ghasemi, BSc¹, Andrew Warner, MSc¹, John Yoo, MD¹, Kevin Fung, MD¹, Danielle Macneil, MD¹, David Palma, MD, PhD¹, John W Barrett, PhD¹, Anthony C Nichols, MD¹

¹Western University, ²Ontario Institute for Cancer Research

LYMPH NODE YIELD RATIO AS A PREDICTOR OF SURVIVAL IN ORAL CAVITY SQUAMOUS CELL CARCINOMA

Mucosal - HPV Negative

Emily Marchiano, MD¹, Andrew C Birkeland, MD², Keith A Casper, MD¹, Andrew G Shuman, MD¹, J. Chad Brenner, PhD¹, Matthew E Spector, MD¹, Steven B Chinn, MD, MPH¹

¹University of Michigan, ²Stanford University

PRIMARY LARYNGECTOMY VERSUS SALVAGE LARYNGECTOMY: A COMPARISON OF THE FUNCTIONAL AND ONCOLOGIC OUTCOMES

Mucosal - HPV Negative

Christopher B Sullivan, MD¹, Katherine Ostedgaard, MD², Steven Sperry, MD³

¹University of Iowa, ²University of California at Davis, ³Department of Otolaryngology – Head and Neck Surgery, Aurora St. Luke’s Medical Center

HEAD AND NECK CANCER DEMONSTRATES SUBSTANTIAL CHANGES IN LIPID METABOLISM.

Mucosal - HPV Negative

James A Higginson¹, Gavin R Lloyd², Andris Jankevics², Martin R Jones³, Rachel Spruce¹, Anthony Kong¹, Ralf J Weber², Hisham Mehanna¹, Andrew D Southam², Nikolaos Batis¹

¹Institute of Cancer and Genomic Sciences, University of Birmingham, ²Phenome Center Birmingham, School of Biosciences, University of Birmingham, ³School of Biosciences, University of Birmingham

PROGNOSTIC FACTORS RELATED TO THE NECK METASTASIS OF ORAL CANCER.

Mucosal - HPV Negative

Luiz P Kowalski

A C Camargo Cancer Center

LARYNGEAL CANCER IN YOUNG- AND MIDDLE-AGED PATIENTS: AN EVALUATION OF RISK FACTORS, HPV STATUS AND OUTCOMES

Mucosal - HPV Negative

Calvin X Geng, MS, Priscilla Tanamal, MS, Ellen Wang, MD, Simone Arvisais-Anhalt, MD, Justin Bishop, MD, Baran Sumer, MD, John Truelson, MD, Larry Myers, MD, Brittny Tillman, MD, Lenka Stankova, MD, Eli Gordin, MD, Kathleen Tibbetts, MD, Ted Mau, MD, Lesley Childs, MD, Andrew T Day, MD, MPH

UT Southwestern

OUTCOMES FOR THE TREATMENT OF RECURRENT NASOPHARYNGEAL CANCER: A SYSTEMATIC REVIEW AND POOLED ANALYSIS

Mucosal - HPV Negative

Ethan Newton, MD, BSc¹, Dianne Valenzuala, MD, BSc¹, Joshua Foley, BSc², Eitan Prisman, MD, MA, FRCSC¹, Andrew Thamboo, MD, FRCSC, MHSc¹

¹University of British Columbia, Department of Otolaryngology Head and Neck Surgery, ²University of British Columbia Faculty of Medicine

BEYOND DEPTH OF INVASION: ADVERSE PATHOLOGIC TUMOR FEATURES IN EARLY ORAL TONGUE SQUAMOUS CELL CARCINOMA

Mucosal - HPV Negative

Andrew Larson, MD, Emily Chan, MD, PhD, Jacquelyn Kemmer, BA, Patrick Ha, MD, Jonathan George, MD, William Ryan, MD, Chase Heaton, MD

University of California, San Francisco

EVALUATION OF OVERALL SURVIVAL USING NUMBER OF NODES FOR PATHOLOGIC STAGING IN P16-NEGATIVE HEAD AND NECK CANCER

Mucosal - HPV Negative

Andrew J Coniglio, MD, Douglas R Farquhar, MD, Siddharth Sheth, MD, Maheer M Masood, Samip Patel, MD, Adam M Zanation, MD, Mark C Weissler, MD, Andrew F Olshan, PhD, Samip N Patel, MD, Trevor G Hackman, MD

University of North Carolina

SURVIVAL IN PATIENTS WITH HEAD AND NECK MUCOSAL MELANOMA

Mucosal - HPV Negative

Felipe Cardemil, MD, Lily Wang, David Goldstein, MD, Anna Spreafico, MD, Andrew Bayley, MD, Ralph Gilbert, MD, Jonathan Irish, MD, Dale Brown, MD, Douglas Chepeha, MD, Patrick Gullane, MD, John de Almeida, MD

University of Toronto